BATS BZX Real-Time Price
As of 3:15pm ET
| -0.40 / -2.62%|
The 5 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 50.00, with a high estimate of 55.00 and a low estimate of 35.00. The median estimate represents a +236.47% increase from the last price of 14.86.
The current consensus among 6 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.